EU's Advisory Panel Clears BMS/Pfizer's Apixaban; Turns Down Vectibix Extension
This article was originally published in The Pink Sheet Daily
Executive Summary
Europe's scientific advisory committee, the CHMP, gives positive opinions on apixaban and Viropharma's Cinryze, but doesn't want Vectibix's indications extended.